Target intelligence / Profile preview

Tubulin alpha pseudogene 13 (TUBAP13)

Target
TUBAP13
Molecular classification
Other (Pseudogene)
01

Overview

Tubulin alpha pseudogene 13 (TUBAP13) is classified as a pseudogene annotation in databases, not as a protein-coding gene or functional molecular target. It is annotated as a pseudogene in the human genome and does not encode a functional protein product. While the human genome contains many functional alpha-tubulin genes (such as TUBA1A, TUBA4A, etc.), as well as numerous pseudogenes, TUBAP13 is classified among the latter. Pseudogenes do not produce functional proteins and are generally regarded as non-functional genetic elements, often the result of gene duplication or retrotransposition events followed by the accumulation of disabling mutations. TUBAP13 is a pseudogene, not a canonical molecular target. It has no established protein product, biological function, therapeutic relevance, or associated disease role. The well-studied functional tubulin alpha genes (e.g., TUBA1A, TUBA4A, TUBA3C) encode proteins essential to microtubule structure and dynamics and may be involved in disease when mutated. Pseudogenes, by definition, are non-functional in terms of protein coding and are not considered valid molecular targets for therapeutics or drug discovery. There is no evidence that "tubulin alpha pseudogene 13" (TUBAP13) produces a protein or acts as a receptor, enzyme, transporter, or any other recognized therapeutic molecular target class. If an alpha-tubulin protein, microtubule, or cytoskeletal drug/therapeutic target is intended, refer to canonical genes such as Tubulin alpha-1a (TUBA1A) or Tubulin alpha-4a (TUBA4A) instead.

Other names
tubulin alpha 4a pseudogeneTUBAP13

Beyond the preview

Go deeper on Tubulin alpha pseudogene 13 (TUBAP13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin alpha pseudogene 13 (TUBAP13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call